This is a general term for any problem with the white part of your eye, called the sclera. These problems can be caused by different things, like birth defects or age-related changes.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Scleral diseases are conditions that affect the sclera, the tough white outer wall of the eyeball. The sclera gives the eye its shape, protects the delicate structures inside it and anchors the muscles that move the eye. "Scleral diseases" is an umbrella term rather than a single diagnosis: it covers inflammation, thinning, structural differences present from birth and changes in the color of the white of the eye. The most important of these is scleritis, inflammation of the sclera itself. It typically causes a deep, severe ache in the eye along with redness, tenderness, tearing and sensitivity to light, and without treatment it can damage vision. Scleritis is rare. It is often confused with episcleritis, a much more common inflammation of the thin layer of tissue lying on top of the sclera. Episcleritis turns part of the white of the eye pink or red and can be uncomfortable, but it is usually mild and vision stays normal. Scleritis is grouped by where it occurs. Anterior scleritis, at the front of the eye, is the more common kind. It can be diffuse (spread over part or all of the visible sclera), nodular (forming tender, deep red bumps) or necrotizing, the most severe type, in which inflammation destroys scleral tissue. Posterior scleritis, at the back of the eye, is rarer and harder to see from the outside, and it more often threatens vision. One unusual form, scleromalacia perforans, thins the sclera with little or no pain, so it can progress quietly. Some scleral changes are not inflammatory at all. A blue or gray tint to the whites of the eyes, for example, is a recognized feature of milder forms of osteogenesis imperfecta, an inherited condition that makes bones fragile.
Scleritis is closely tied to the immune system. In many people it occurs alongside an autoimmune or inflammatory disease, in which the immune system attacks the body's own tissues. Rheumatoid arthritis is the most frequent association. Others include vasculitis (inflammation of blood vessels, including granulomatosis with polyangiitis, a vasculitis that often affects the sinuses, lungs and kidneys), lupus, inflammatory bowel disease, Sjögren's syndrome, sarcoidosis and some forms of inflammatory arthritis of the spine. Scleritis is sometimes the first sign of one of these diseases, which is one reason it deserves a careful workup. In other people no cause is ever found. Less often, scleritis is caused by an infection, such as a herpes virus (including the virus that causes shingles), tuberculosis or syphilis. Eye surgery, most often cataract surgery or removal of a pterygium (a fleshy growth on the surface of the eye), and eye injuries can trigger scleritis near the affected area. A few medicines have also been linked to it, including bisphosphonate medicines used to strengthen bones (pills or infusions) and immune checkpoint inhibitors used in cancer treatment. Scleritis is more common in women than in men. Smoking has been associated with slower response to treatment, more frequent recurrences and greater vision loss, although it has not been shown to cause scleritis. Episcleritis frequently has no identifiable cause, though it can occur with rheumatoid arthritis and some infections. Inherited scleral differences, such as the blue sclera of osteogenesis imperfecta, come from the underlying genetic condition rather than from anything a person did.
An ophthalmologist (a medical doctor who specializes in the eye) diagnoses scleritis mainly by examining the eye. Using a slit lamp, a microscope with a bright light, the doctor looks at how deep the inflamed blood vessels lie and what color they give the eye. In scleritis the swollen vessels are deep and often give the white of the eye a bluish-violet hue, and the eyeball is usually tender to touch. In episcleritis the vessels are more superficial and redder. Eye drops that shrink surface blood vessels can help tell the two apart: the redness of episcleritis fades, while the deeper redness of scleritis does not. Episcleritis usually needs no further testing. Posterior scleritis may cause little visible redness, so imaging helps. An ultrasound of the eye can show thickening of its back wall, and optical coherence tomography (OCT), a scan that uses light to make detailed cross-sectional pictures, can reveal fluid or swelling in the retina. Because scleritis is so often connected to disease elsewhere in the body, diagnosis also means looking for that connection. The doctor will ask about joint pain, rashes, breathing or kidney problems, past eye surgery, current medicines and possible exposure to infection. Blood tests commonly look for markers of rheumatoid arthritis, vasculitis and lupus, and testing for syphilis and tuberculosis, often with a chest X-ray, helps rule out infection, which needs different treatment. The eye doctor frequently works with a rheumatologist, a specialist in autoimmune disease, to complete the picture.
Treatment depends on which condition is present, what is driving it and how severe it is. Episcleritis often clears on its own within one to two weeks. Steroid eye drops or an anti-inflammatory medicine taken by mouth can help symptoms settle sooner. Scleritis needs prompt treatment to protect vision. When there is no infection, the usual approach is to control the inflammation with the least intensive treatment that works and to step up quickly if it does not. Milder anterior scleritis is often treated first with nonsteroidal anti-inflammatory drugs (NSAIDs) taken by mouth, such as ibuprofen, naproxen or indomethacin, sometimes with steroid eye drops. NSAIDs control scleritis in some people but not all, and they carry risks to the stomach, kidneys and heart that matter more after age 65; they are also avoided late in pregnancy. If NSAIDs are not enough, or if the scleritis is posterior or necrotizing, steroid pills such as prednisone, or high-dose steroids given through a vein, are the next step. Steroids work quickly but are not a long-term answer, because of effects such as weight gain, mood and sleep changes, and higher blood sugar and blood pressure. About half of people with scleritis eventually need a steroid-sparing medicine: an immune-modifying drug taken over the long term to keep inflammation controlled without high steroid doses. Methotrexate is a common first choice, with mycophenolate, azathioprine and cyclosporine as alternatives. When these are not enough, biologic medicines that block specific signals in the immune system, such as the tumor necrosis factor (TNF) inhibitors adalimumab and infliximab, or rituximab, are increasingly used. These medicines raise the risk of infection and need regular monitoring, often with blood tests. Methotrexate and mycophenolate can cause birth defects, so a person who could become pregnant needs to stop them well before trying to conceive and use reliable contraception while taking them. Men taking these medicines should discuss plans to father a child with their doctor, because the advice differs. When rheumatoid arthritis or vasculitis is also present, doctors often choose a medicine that treats both. Necrotizing scleritis is usually treated aggressively from the start. Scleritis caused by infection is treated with medicines aimed at the specific organism. Surgery is reserved for severe thinning or a hole in the sclera, when the weak area can be reinforced with a graft of donor tissue. People with a thinned sclera may be advised to wear protective eyewear, especially while sleeping.
Episcleritis usually settles within a couple of weeks and leaves no lasting damage, although it can come back. Rarely, it is followed by true scleritis. Scleritis is usually a longer process. Inflammation can take weeks to bring under control, and flares after improvement are common. Many people therefore stay on treatment for months or years, with regular visits to the eye doctor and often a rheumatologist, plus the routine blood tests that long-term immune-modifying medicines require. The pain of active scleritis can be intense and can disturb sleep, so getting the inflammation under control often makes a large difference to daily life. The outlook depends heavily on the type. Diffuse anterior scleritis, the most common form, is also the most treatable. Necrotizing and posterior scleritis are more likely to cause lasting problems such as glaucoma, swelling or detachment of the retina, or permanent loss of vision, which is why they are treated more aggressively. When scleritis is linked to a disease elsewhere in the body, that disease and its treatment shape the overall picture, and controlling one often helps the other. Stopping smoking is a low-risk step that may help the eye respond to treatment.
Arrange an eye exam if redness in the white of one or both eyes lasts more than about two weeks or keeps coming back, particularly if you have rheumatoid arthritis or another autoimmune condition. Contact an eye doctor right away, ideally the same day, if eye redness comes with deep or worsening eye pain, pain that wakes you at night or spreads to your face, jaw or head, an eyeball that is tender to touch, sensitivity to light, or blurred or reduced vision. These features point toward scleritis rather than a minor irritation, and early treatment protects sight. A darkening or bluish patch spreading on the white of the eye also needs same-day care, because it can mean the sclera is thinning. So do sudden new floaters, flashes of light, a shadow over part of your vision or a sudden change in vision, even if the eye is not red, since scleritis at the back of the eye can affect the retina with little visible redness. If you are already being treated, contact your care team promptly if symptoms return or if medicine side effects become hard to manage.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Scleral Diseases is like, what's helped you, or ask the community a question.